Dilnawaz Fahima, Sahoo Sanjeeb Kumar
Laboratory of Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar 751023, Odisha, India.
Laboratory of Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar 751023, Odisha, India.
Drug Discov Today. 2015 Oct;20(10):1256-64. doi: 10.1016/j.drudis.2015.06.008. Epub 2015 Jun 21.
The diseases of the central nervous system (CNS) represent one of the fastest growing areas of concern requiring urgent medical attention. Treatment of CNS ailments is hindered owing to different physiological barriers including the blood-brain barrier (BBB), which limits the accessibility of potential drugs. With the assistance of a nanotechnology-based drug delivery strategy, the problems could be overcome. Recently, magnetic nanoparticles (MNPs) have proven immensely useful as drug carriers for site-specific delivery and as contrast agents owing to their magnetic susceptibility and biocompatibility. By utilizing MNPs, diagnosis and treatment of CNS diseases have progressed by overcoming the hurdles of the BBB. In this review, the therapeutic aspect and the future prospects related to the theranostic approach of MNPs are discussed.
中枢神经系统(CNS)疾病是急需医疗关注且增长最快的关注领域之一。由于包括血脑屏障(BBB)在内的不同生理屏障限制了潜在药物的可及性,中枢神经系统疾病的治疗受到阻碍。借助基于纳米技术的药物递送策略,这些问题有望得到解决。近年来,磁性纳米颗粒(MNPs)因其磁化率和生物相容性,已被证明作为药物载体用于特定部位递送以及作为造影剂非常有用。通过利用磁性纳米颗粒,中枢神经系统疾病的诊断和治疗在克服血脑屏障障碍方面取得了进展。在本综述中,将讨论与磁性纳米颗粒的诊疗方法相关的治疗方面及未来前景。